Omalizumab in Japanese children with severe allergic asthma uncontrolled with standard therapy

Omalizumab in Japanese children with severe allergic asthma uncontrolled with standard therapy

Background: Omalizumab has demonstrated clinical benefits in children with moderate to severe allergic asthma. However, no studies have been performed in Japanese asthmatic children. The aim of this study was to evaluate the efficacy including free IgE suppression and safety of omalizumab in Japanes...

Full description

Bibliographic Details
Main Authors: Hiroshi Odajima, Motohiro Ebisawa, Toshikazu Nagakura, Takao Fujisawa, Akira Akasawa, Komei Ito, Satoru Doi, Koichi Yamaguchi, Toshio Katsunuma, Kazuyuki Kurihara, Naomi Kondo, Kazuko Sugai, Mitsuhiko Nambu, Akira Hoshioka, Shigemi Yoshihara, Norio Sato, Noriko Seko, Sankei Nishima
Format: Article
Language:English
Published: Elsevier 2015-10-01
Series:Allergology International
Subjects:
Bronchial asthma
Children
Japanese
Omalizumab
Quality of life
Online Access:http://www.sciencedirect.com/science/article/pii/S132389301500115X

Internet

http://www.sciencedirect.com/science/article/pii/S132389301500115X

Similar Items